A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities
EMC MM-04-54-08-A
Medicin och hälsovetenskap
Registry
Pharmacosurveillance
Adolescent
VDP::Medisinske Fag: 700::Helsefag: 800::Epidemiologi medisinsk og odontologisk statistikk: 803
610
Diseases of the musculoskeletal system
Medical and Health Sciences
Pediatrics
RJ1-570
Cohort Studies
03 medical and health sciences
0302 clinical medicine
VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Pediatri: 760
Observational study
Journal Article
VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Pediatrics: 760
Humans
Pediatric rheumatology
Registries
Child
Juvenile idiopathic arthritis; Observational study; Pediatric rheumatology; Pharmacosurveillance; Registry;
Australia
VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Rheumatology: 759
Juvenile idiopathic arthritis
001
Arthritis, Juvenile
3. Good health
VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Reumatologi: 759
Europe
Observational Studies as Topic
VDP::Medical disciplines: 700::Health sciences: 800::Epidemiology medical and dental statistics: 803
RC925-935
Research Design
Antirheumatic Agents
North America
Research Article
DOI:
10.1186/s12969-017-0161-5
Publication Date:
2017-04-19T00:16:21Z
AUTHORS (23)
ABSTRACT
To characterize the existing national and multi-national registries cohort studies in juvenile idiopathic arthritis (JIA) identify differences as well areas of potential future collaboration. We surveyed investigators from North America, Europe, Australia about JIA registries. excluded cross-sectional studies. captured information study design, duration, location, inclusion criteria, data elements collection methods. received survey results 18 studies, including 11 7 representing 37 countries total. Study designs included inception cohorts, prevalent disease new treatment cohorts (several which contribute to pharmacosurveillance activities). Despite numerous differences, collected across was quite similar, with most collecting at least 5 6 American College Rheumatology core set variables needed calculate 3-variable clinical activity score. Most were medication initiation discontinuation dates attempting capture serious adverse events. There is a wide-range large, ongoing around world. Our indicate significant for collaborative work using different both combined comparative analyses.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (39)
CITATIONS (25)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....